Related by context. All words. (Click for frequent words.) 82 comorbid conditions 81 comorbidity 75 co morbidities 69 comorbid 68 prognostic factors 68 confounding variables 67 covariates 66 psychiatric comorbidities 66 multivariate analyzes 66 covariate 65 renal insufficiency 65 perioperative complications 65 prognostic variables 65 potential confounders 65 psychiatric comorbidity 65 sociodemographic factors 64 MetS 64 depressive symptomatology 64 confounders 64 carotid IMT 64 MMSE scores 63 MMSE score 63 preoperative 63 HRQL 63 postoperative AF 63 hypertension diabetes mellitus 63 comorbid disorders 63 logistic regression model 63 postoperative complication 63 comorbid illnesses 63 carotid stenosis 63 HRQoL 63 renal dysfunction 63 fragility fracture 63 Complication rates 62 LUTS 62 macrovascular disease 62 univariate analysis 62 nondiabetic patients 62 renal impairment 62 biochemical recurrence 62 morbidities 62 nonoperative treatment 62 % CI #.#-#.# [006] 62 beta blocker therapy 62 left ventricular dysfunction 62 multivariable analyzes 62 comorbid depression 62 adenomatous polyps 62 subgroup analyzes 62 autonomic dysfunction 62 sociodemographic characteristics 62 P = .# 62 vertebral fracture 62 hypoglycemic events 62 β blockers 62 thromboembolic 62 univariate analyzes 62 postoperative complications 62 lymph node involvement 62 Subgroup analyzes 61 subclinical hypothyroidism 61 perioperative mortality 61 advanced adenomas 61 neovascular glaucoma 61 noncardiac 61 multivariate analysis 61 subtrochanteric 61 preoperative PSA 61 androgen deficiency 61 extrapyramidal symptoms 61 HRQOL 61 subclinical hyperthyroidism 61 coronary calcification 61 MACCE 61 nonfatal MI 61 adenotonsillectomy 61 elevated LDH 61 affective psychoses 61 confounding factors 61 logistic regression models 61 tumor histology 61 subclinical atherosclerosis 61 depressive symptoms 61 obstructive CAD 61 revascularization procedures 61 nodal metastases 61 nonfasting triglyceride levels 61 MGUS 61 prostate cancer CaP 60 antihypertensive medications 60 nonadherence 60 chronicity 60 advanced neoplasia 60 T2DM 60 NAFLD 60 cardiovascular comorbidities 60 neurocognitive function 60 androgen deprivation 60 familial clustering 60 TEAEs 60 Exclusion criteria 60 postoperative mortality 60 postoperative delirium 60 neurocognitive deficits 60 multivariate logistic regression 60 logistic regression analysis 60 neurologic complications 60 nonobese 60 LV dysfunction 60 VUR 60 radical prostatectomy RP 60 sociodemographic variables 60 cerebral infarction 60 thromboembolic events 60 CVD mortality 60 TAVR 60 postoperative radiotherapy 60 preoperative chemotherapy 60 NNT = 60 EDSS scores 60 coronary revascularization 60 systolic dysfunction 60 IPAH 60 renal artery stenosis 60 reflux symptoms 60 antihypertensive therapy 60 postoperative infections 60 abdominal adiposity 60 pathologic fractures 59 diabetes mellitus 59 hypoxemia 59 somatic symptoms 59 EBRT 59 multivessel disease 59 neurocognitive impairment 59 postoperative morbidity 59 acetabular dysplasia 59 primary aldosteronism 59 neurological abnormalities 59 BMI z 59 arterial thromboembolic events 59 oncologic outcomes 59 hemorrhagic complications 59 urolithiasis 59 CABG 59 adverse cytogenetics 59 reoperations 59 HbA 1c levels 59 psychiatric morbidity 59 HbA1c levels 59 perioperative morbidity 59 syndromal 59 cranial irradiation 59 univariate 59 ischemic cardiomyopathy 59 OAB symptoms 59 urinary symptoms 59 dysthymia 59 statin therapy 59 microalbuminuria 59 unmeasured confounders 59 preoperatively 59 APOE genotype 59 psychosocial functioning 59 nonvertebral fractures 59 gestational diabetes mellitus 59 lipid lowering agents 59 atherosclerotic disease 59 femoral neck fracture 59 thyrotropin levels 59 confidence intervals CIs 59 comorbid psychiatric 59 periprocedural 59 carotid plaques 59 coexisting illnesses 59 nondepressed 59 oxygen desaturation 59 multivariable analysis 59 cardiovascular mortality 59 nonvertebral fracture 59 undergoing CABG 59 metabolic abnormalities 59 coronary artery calcium 59 postoperative pulmonary 59 microbleeds 59 lipid lowering medications 59 SLNB 59 liver transplant recipients 59 vertebral fractures 58 elevated IOP 58 loop diuretics 58 warfarin therapy 58 bivariate analyzes 58 infarctions 58 cerebrovascular accident 58 nonischemic 58 symptomatic intracerebral hemorrhage 58 OSAHS 58 concomitant medications 58 myocardial infarction MI 58 hematologic toxicity 58 nulliparous women 58 COPD exacerbation 58 neurodevelopmental impairment 58 adjuvant chemotherapy 58 coronary stenosis 58 sociodemographic 58 antibiotic prophylaxis 58 radical nephrectomy 58 hallux valgus 58 HIV HCV coinfected 58 adjuvant therapies 58 lower extremity amputation 58 obstetric complications 58 microvascular disease 58 Multivariate analyzes 58 dopaminergic therapy 58 thromboembolism 58 impaired cognition 58 alexithymia 58 gallstone disease 58 CI #.#-#.# [001] 58 thyroid nodules 58 Preoperatively 58 morbidity 58 antihypertensive medication 58 contralateral breast cancer 58 CTEPH 58 adenoidectomy 58 nephron sparing surgery 58 Depressive symptoms 58 renal tumors 58 vesicoureteral reflux 58 proliferative diabetic retinopathy 58 epididymitis 58 obstructive coronary artery 58 hypersomnia 58 antiplatelet agents 58 NYHA class 58 hip BMD 58 typical antipsychotics 58 HNSCC 58 symptom severity 58 cerebral microbleeds 58 renal function 58 laboratory abnormalities 58 nonoperative 58 pulmonary resection 58 affective disorder 58 left ventricular hypertrophy 58 asymptomatic PAD 58 cardiovascular disease hypertension 58 HbA1C levels 58 confidence interval #.#-#.# 58 multivariable adjusted 58 nasal obstruction 58 SGAs 58 distant metastases 58 polyp recurrence 58 Kaplan Meier analysis 58 atherothrombotic 58 carotid plaque 58 Charlson comorbidity index 58 aldosterone antagonist 58 thromboprophylaxis 58 NIHSS score 58 affective disorders 58 poststroke 58 Univariate analysis 58 psychosocial variables 58 coinfected patients 58 CHD mortality 57 platelet reactivity 57 immunosuppressive medications 57 POAG 57 hypoglycemic episodes 57 paclitaxel eluting stents 57 empyema 57 ALT flares 57 Postoperative 57 lymphadenectomy 57 coronary artery calcification 57 adrenalectomy 57 treated nonoperatively 57 pericardial effusion 57 juvenile idiopathic arthritis 57 multivariate adjustment 57 Baseline characteristics 57 isolated systolic hypertension 57 ADHF 57 histologically confirmed 57 urothelial carcinoma 57 premorbid 57 polyarticular 57 atherothrombotic disease 57 asthma exacerbations 57 metabolic parameters 57 venous thromboembolic disease 57 affective psychosis 57 residual confounding 57 macroalbuminuria 57 macrovascular events 57 % CI #.#-#.# [007] 57 subscore 57 postoperative atrial fibrillation 57 left ventricular systolic 57 transferrin saturation 57 LVEF 57 reinfarction 57 artery stenosis 57 SRBD 57 unmeasured factors 57 normotensive 57 cognitive impairment 57 acetabular fractures 57 antiplatelet drugs 57 thrombophilia 57 underwent resection 57 atypical hyperplasia 57 multivariate Cox 57 LVSD 57 lung resections 57 myocardial ischemia 57 virologic failure 57 etiologies 57 extracapsular extension 57 tamsulosin 57 Cognitive impairment 57 Comorbidities 57 radiotherapy RT 57 recurrent tonsillitis 57 carotid endarterectomy 57 axillary node dissection 57 squamous cell histology 57 colorectal neoplasia 57 undergoing radical prostatectomy 57 cystectomy 57 antimicrobial prophylaxis 57 glucocorticoid therapy 57 esophagitis 57 cognitively intact 57 androgen suppression 57 chemoradiation 57 hyperbilirubinemia 57 Postoperative complications 57 preoperative diagnosis 57 adnexal mass 57 revascularization 57 T1a 57 nomograms 57 lowest tertile 57 hippocampal volumes 57 atheroma volume 57 hepatorenal syndrome 57 resections 57 oral anticoagulation 57 confidence interval CI 57 anticoagulation therapy 57 GERD symptoms 57 calculi 57 radiographic findings 57 periprocedural MI 57 postdischarge 57 radical cystectomy 57 intracerebral haemorrhage 57 hypertension 57 conventional angiography 57 Multivariate analysis 57 venous thrombosis 57 neurologic abnormalities 57 intima media thickness 57 gastrointestinal GI bleeding 57 TNF antagonist 57 decompensated cirrhosis 57 prostate TURP 57 syndromic 57 severe hypoglycemia 57 systolic hypertension 57 adjuvant therapy 57 myocardial infarction stroke 57 methotrexate therapy 57 Comorbid 57 atherogenic dyslipidemia 57 inflammatory biomarkers 57 neurologic symptoms 57 % CI #.#-#.# [004] 57 pharmacologic treatments 57 ELBW infants 57 neurologic impairment 57 hemoglobin A1c levels 57 infarcts 57 atrophic gastritis 57 highest tertile 57 BMD measurements 57 asthma exacerbation 57 angiographically 57 creatinine clearance 57 post thrombotic syndrome 56 endometrial thickness 56 postintervention 56 stenoses 56 albuminuria 56 nonpsychiatric 56 aminotransferases 56 pyelonephritis 56 Comorbidity 56 congenital anomalies 56 mammographic density 56 systolic BP 56 thromboembolic complications 56 EDSS score 56 VTEs 56 incomplete revascularization 56 GnRH agonists 56 BMI ≥ 56 prognostic indicators 56 nephropathy 56 nonmelanoma skin cancers 56 prespecified secondary 56 advanced adenoma 56 cytogenetic abnormalities 56 glycated hemoglobin levels 56 colorectal adenoma 56 colorectal adenomas 56 Logistic regression analysis 56 PSADT 56 lipid abnormalities 56 pCR 56 lipid lowering therapy 56 potentially modifiable 56 socioeconomic status 56 sequelae 56 DMARD 56 CI = 56 pulmonary dysfunction 56 % CI #.#-#.# [008] 56 abdominal circumference 56 uncontrolled hypertension 56 neurocognitive functioning 56 HRCT 56 cirrhotic patients 56 atherothrombosis 56 symptomatology 56 pelvic lymphadenectomy 56 comorbid anxiety 56 potential confounding variables 56 postoperative chemotherapy 56 nonrandomized 56 neuropsychiatric symptoms 56 intraobserver 56 SCr 56 hypertensives 56 neurologic sequelae 56 amenorrhoea 56 definite stent thrombosis 56 underlying pathophysiology 56 postop 56 ECOG PS 56 ICD implantation 56 hyperglycaemia 56 colorectal polyps 56 endometrial carcinoma 56 Sleep disordered breathing 56 antithrombotic therapy 56 paroxysmal AF 56 cytoreductive surgery 56 underwent radical prostatectomy 56 ATACAND 56 serum creatinine levels 56 NIHSS 56 EQ 5D 56 postoperative 56 proteinuria 56 chronic pancreatitis 56 suicide attempters 56 logistic regression analyzes 56 histological subtype 56 carotid artery stenosis 56 NATRECOR ® 56 VTE prophylaxis 56 baseline LDH 56 % CI #.#-#.# [005] 56 methotrexate monotherapy 56 intracranial stenosis 56 HF hospitalization 56 preserved ejection fraction 56 cryptorchidism 56 APTIVUS r 56 preintervention 56 depressive symptom 56 unipolar depression 56 Charlson Comorbidity Index 56 confounder 56 CC genotype 56 habitual snoring 56 detrusor overactivity 56 glycoprotein IIb IIIa inhibitors 56 patients undergoing CABG 56 QoL 56 PCa 56 RLS symptoms 56 microvascular complications 56 adjuvant radiotherapy 56 Logistic regression 56 Excessive daytime sleepiness 56 comorbid diagnoses 56 systolic function 56 psychiatric diagnoses 56 Heavy menstrual bleeding 56 cardiometabolic risk 56 knee OA 56 immunosuppressive agents 56 nondiabetic 56 underdiagnosis 56 hydronephrosis 56 hypopituitarism 56 predisposing factors 56 ALND 56 monoclonal gammopathy 56 ICD therapy 56 reperfusion therapy 56 thoracoscopic lobectomy 56 serum creatinine 56 nodal metastasis 56 posttransplant 56 hematopoietic cancers 56 highest quintile 56 APACHE II 56 coronary artery stenosis 56 myopia nearsightedness 56 antiarrhythmic medications 56 HbA 1c 56 transurethral resection 56 hyperglycemia 56 hypovitaminosis D 56 T1DM 56 nephrolithiasis 56 recurrent UTI 56 microscopic hematuria 56 impaired glucose metabolism 56 modifiable risk 56 acute coronary syndromes 56 antidiabetic drugs 56 serum PTH 56 coronary artery disease 56 NSTEMI 56 transaminase elevations 56 familial aggregation 56 tertile 56 nonalcoholic steatohepatitis NASH 56 elevated serum creatinine 56 uncontrolled asthma 56 somatoform disorder 56 anastomotic leak 56 pulmonary exacerbations 56 sleep disordered breathing 56 carotid atherosclerosis 56 perinatal outcomes 56 subsyndromal 56 posttreatment 56 laterality 56 extensive metabolizers 56 hemodialysis patients 56 pancreatectomy 56 Secondary endpoints 56 total knee arthroplasty 56 polypharmacy 56 coagulopathy 56 analgesic medications 55 pretest probability 55 Meta analyzes 55 coronary revascularization procedures 55 poorer prognosis 55 ipsilateral stroke 55 diabetes mellitus DM 55 intracerebral hemorrhage 55 allele frequencies 55 varicocele 55 myocardial infarctions 55 UA NSTEMI 55 overt nephropathy 55 BRCA1 mutation carriers 55 undergoing bariatric surgery 55 psychiatric disorders 55 calcaneal fractures 55 hip fracture 55 vestibular dysfunction 55 hamartomas 55 diabetes hypertension hyperlipidemia 55 dysglycemia 55 progressive dyspnea 55 genotypic resistance 55 unfavorable prognostic 55 plain radiographs 55 symptomatic hyponatremia 55 hematuria 55 symptomatic VTE 55 GI bleeding 55 occlusive disease 55 odds ratios ORs 55 neuropsychological impairments 55 supratentorial 55 parathyroidectomy 55 nonalcoholic steatohepatitis 55 NYHA functional class 55 recurrent ischemia 55 corticosteroid therapy 55 Erythropoietic therapies may 55 LV ejection fraction 55 neoplastic 55 Adjuvant chemotherapy 55 lymph node metastases 55 locoregional recurrence 55 mild renal insufficiency 55 cTnT 55 therapeutic regimens 55 predisposing factor 55 renal transplantation 55 locoregional 55 juvenile idiopathic arthritis JIA 55 sotalol 55 pretransplant 55 hyperkalemia 55 p = #.# [003] 55 graft occlusion 55 MS DRGs 55 bivariate 55 cardioembolic stroke 55 conditional logistic regression 55 catheter angiography 55 elevated CRP 55 Radical prostatectomy 55 Hurthle cell 55 postsurgical 55 white matter hyperintensities 55 fragility fractures 55 severe aortic stenosis 55 anticholinergic drugs 55 uncontrolled seizures 55 lipid parameters 55 nephrectomy 55 venous thromboembolism prophylaxis 55 recurrent DVT 55 systolic blood pressures 55 lacunar 55 extracolonic findings 55 variceal bleeding 55 baseline HbA1c 55 meningiomas 55 clinically localized prostate 55 % CI #.#-#.# [003] 55 carotid intima media 55 regression analyzes 55 pulmonary nodules 55 noncardiovascular mortality 55 Genetic variants 55 clinically meaningful improvements 55 Operative mortality 55 FFR measurements 55 chronic renal insufficiency 55 bilateral oophorectomy 55 ICD shocks 55 dyslipidaemia 55 fibroids endometriosis 55 pharmacological interventions 55 relapsed AML 55 estimated glomerular filtration 55 hippocampal volume 55 hypercholesterolemia 55 androgen excess 55 lymph node dissection 55 cerebrovascular events 55 coronary calcium 55 underwent CABG 55 nonobstructive 55 pT3 55 stable angina 55 euthymic patients 55 moderate renal impairment 55 endosonography 55 chorioamnionitis 55 gastric atrophy 55 malperfusion 55 BRCA1 mutations 55 atopic 55 medication nonadherence 55 morbidity mortality 55 parkinsonism 55 hypercalciuria 55 AUDs 55 p = #.# [002] 55 hypoglycaemic episodes 55 onset diabetes mellitus 55 acute cholecystitis 55 thrombolytic therapy 55 Univariate 55 prevalences 55 hepatic insufficiency 55 meta regression 55 clinicopathologic 55 RYGB 55 CrCl 55 pathologic fracture 55 decompensated heart failure 55 coronary stenoses 55 elevated triglyceride levels 55 tibiofemoral 55 overactive bladder symptoms 55 neurodevelopmental outcomes 55 spirometric 55 cardiomyopathies 55 femoral fracture 55 intravesical therapy 55 intraoperative complications 55 aortic regurgitation 55 histologic subtype 55 incidentalomas 55 lumbar disk herniation 55 SGRQ 55 stratifying patients 55 ruptured aneurysms 55 bowel resection 55 hypercoagulable 55 subthreshold depression 55 thrombotic events 55 endarterectomy 55 acetabular fracture 55 ACC AHA 55 MS DRG 55 pathologic 55 fasting insulin 55 authors conclude 55 hepatectomy 55 anticholinergic medications 55 CI #.#-#.# [002] 55 QTc 55 coronary blockages 55 invasive coronary angiography 55 androgen deprivation therapy 55 aneurysmal subarachnoid hemorrhage 55 myocardial infarction 55 somatoform disorders 55 rebleeding 55 hematologic adverse 55 asymptomatic 55 intraventricular hemorrhage 55 pT2 55 index BMI 55 neoplasms 55 nonobese patients 55 undergoing coronary angiography 55 CORE OM 55 logistic regression 55 revascularizations 55 ischemic lesions 55 elevated ALT 55 disk herniation 55 MDRD equation 55 colectomy 55 partial nephrectomy 55 bulimia nervosa 55 generalized seizures 55 inhospital mortality 55 coronary angiography 54 congenital abnormalities 54 β blocker 54 SNHL 54 adenoma 54 serum PSA 54 oral hypoglycemic agents 54 femoral neck fractures 54 intra abdominal abscess 54 neurodevelopmental outcome 54 sonographic findings 54 NNRTI resistance 54 curative resection 54 EGFR mutation status 54 HSCT 54 upper airway obstruction 54 primary hyperparathyroidism 54 EXJADE 54 sleeve lobectomy 54 sleep apneas 54 nonpharmacologic 54 pancreatic adenocarcinoma 54 alcoholic fatty liver 54 NMIBC 54 poor metabolizers 54 inhaled corticosteroid therapy 54 BPH LUTS 54 de ath 54 femoral shaft fractures 54 autistic traits 54 BRCA mutations 54 recurrent wheezing 54 neurologic deficits 54 tirofiban 54 menarche 54 histological subtypes 54 liver histology 54 subclinical cardiovascular disease 54 idiopathic scoliosis 54 histopathologic 54 limiting generalizability 54 serum aminotransferase levels 54 virological response 54 % CI #.#-#.# [002] 54 tertiles 54 NPH insulin 54 anal incontinence 54 radical prostatectomy 54 osteochondroma 54 malunion 54 diastolic pressures 54 osteopenic 54 GH deficiency 54 retransplantation 54 recurrent VTE 54 virologic response 54 Stent thrombosis 54 polypoid lesions 54 lymphadenopathy 54 systemic corticosteroids 54 ventricular mass 54 lymph node metastasis 54 onset seizures 54 chronic metabolic acidosis 54 etiologic 54 ß blockers 54 varicoceles 54 nonischemic cardiomyopathy 54 antiarrhythmic drug 54 lifetime abstainers 54 venous thromboembolism 54 atypical fractures 54 Vitamin B# deficiency 54 endometrial cancers 54 mycophenolate mofetil 54 psychotic illnesses 54 estimated GFR 54 gastrectomy 54 WOMAC pain 54 antidiabetic medications 54 T2 lesions 54 Atypical antipsychotics 54 hypertension hypercholesterolemia 54 perforated appendicitis 54 vascular dysfunction 54 testosterone supplementation 54 histologic 54 testicular tumors 54 MDRD 54 nocturnal hypoglycemia 54 rFVIIa 54 endometrial hyperplasia 54 SIADH 54 DMARD therapy 54 virological failure 54 upper gastrointestinal bleeding 54 mIU L 54 generalizability 54 Observational studies 54 perioperatively 54 hyperparathyroidism 54 lipid levels 54 postoperative infection 54 LVNC 54 breast abscesses 54 SE alleles 54 impaired renal 54 clinicopathological features 54 acid suppressive medications 54 anticonvulsant medications 54 BRCA mutation 54 oophorectomy 54 VADT 54 TURP 54 atypical antipsychotic medications 54 MELD scores 54 adenomas 54 carotid artery stenting CAS 54 bacterial prostatitis 54 hepatic resection 54 lung lesions 54 multivariable adjustment 54 recurrent atrial fibrillation 54 spinal metastases 54 prospectively defined 54 congenital malformations 54 stepwise logistic regression 54 intact parathyroid hormone 54 structural abnormalities 54 postprocedure 54 metastatic lung cancer 54 severe hypoglycaemia 54 QTc interval 54 diabetes mellitus hypertension 54 nontraumatic 54 intracranial hemorrhage ICH 54 CHD CVD 54 cTnT levels 54 abnormal lipid 54 hyperplastic polyps 54 haematologic 54 underwent coronary angiography 54 CLBP 54 demographic variables 54 reoperation 54 p = .# [002] 54 osteochondromas 54 clinically insignificant 54 flutamide 54 anticoagulation 54 esophagectomy 54 malabsorptive 54 URTI 54 Prehypertension 54 ischemic stroke 54 idiopathic 54 heterotaxy 54 metaplasia 54 socioeconomic variables 54 non selective NSAIDs 54 fasting glucose levels 54 malignant neoplasm 54 obstructive coronary 54 somatic complaints 54 abdominal obesity 54 screening colonoscopy 54 sonographic appearance 54 antihypertensive drugs 54 TMP SMX 54 hypoperfusion 54 subscales 54 prepregnancy BMI 54 hereditary predisposition 54 Preoperative 54 generalized tonic clonic seizures 54 postoperatively 54 severe renal impairment 54 premenopausal 54 inhospital 54 chronic GVHD 54 histologically proven 54 HBV infection 54 prescribed opioids 54 cerebrovascular disease 54 glitazones 54 pharmacologic intervention 54 adiposity 54 oral anticoagulant therapy 54 syncopal 54 aromatase inhibitor therapy 54 pulmonary artery banding 54 LV hypertrophy 54 macrovascular complications 54 antenatal depression 54 Taxus Stent 54 conventional coronary angiography 54 p = .# [001] 54 atrioventricular block 54 osteopathic manipulation 54 neurocognitive impairments 54 bypass grafting 54 normal karyotype 54 VAD implantation 54 p = 54 arteriography 54 F FDG PET 54 seminal vesicle invasion 53 elevated triglycerides 53 cardiac abnormalities 53 neuropsychological deficits 53 femoral neck BMD 53 femoral shaft fracture 53 vasomotor symptoms 53 lymph node removal 53 lopinavir r arm 53 undergoing coronary artery 53 medically inoperable 53 Venous thromboembolism 53 etiology 53 obese adolescents 53 pamidronate 53 hypovolemia 53 lobular cancer 53 sinus node dysfunction 53 GH deficient 53 tumor recurrence 53 serum uric acid 53 levodopa therapy 53 vitamin D inadequacy 53 p = NS 53 proliferative retinopathy 53 pulmonary embolism PE 53 unfavorable cytogenetics 53 untreated celiac disease 53 dose statin therapy